DENTSPLY SIRONA Inc. (XRAY)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 936 | 879 | 951 | 984 |
| Cost of products sold | 446 | 413 | 456 | 473 |
| Gross profit | 490 | 466 | 495 | 511 |
| Goodwill and intangible asset impairments | 235 | - | 504 | - |
| Research and development expenses | 37 | 36 | 40 | 41 |
| Restructuring and other costs | 4 | 9 | 23 | 21 |
| Selling, general, and administrative expenses | 342 | 358 | 390 | 399 |
| Intangible asset impairments | - | - | - | - |
| Operating (loss) income | -128 | 63 | -462 | 50 |
| Interest expense, net | 24 | 19 | 18 | 17 |
| Other expense (income), net | -1 | - | 2 | 1 |
| (loss) income before income taxes | -153 | 44 | -478 | 34 |
| (benefit) provision for income taxes | -109 | 25 | 17 | 38 |
| Net (loss) income | -44 | 19 | -495 | -4 |
| Less net income (loss) attributable to noncontrolling interest | 1 | -1 | -1 | - |
| Net (loss) income attributable to dentsply sirona | -45 | 20 | -494 | -4 |
| Basic (in dollars per share) | -0.22 | 0.1 | -2.46 | -0.02 |
| Basic (in shares) | 199,300,000 | 199,100,000 | 201,000,000 | 205,600,000 |
| Diluted (in dollars per share) | -0.22 | 0.1 | -2.46 | -0.02 |
| Diluted (in shares) | 199,300,000 | 199,800,000 | 201,000,000 | 205,600,000 |